Estrogen and selective estrogen receptor modulator LY117018 enhance release of nitric oxide in rat aorta

Journal of Pharmacology and Experimental Therapeutics

Volumn 283, Issue 1, 1997, Pages 116-122

  Rahimian, Roshanak ^a   Laher, Ismail ^a   Dube, Gregory ^b   Van Breemen, Cornelis ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b ELI LILLY AND COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

6 HYDROXY 2 (4 HYDROXYPHENYL) 3 [4 [2 (1 PYRROLIDINYL)ETHOXY]BENZOYL]BENZO[B]THIOPHENE; ARGININE METHYL ESTER; ESTRADIOL; ESTROGEN RECEPTOR; NITRIC OXIDE; PROGESTERONE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; AORTA; ARTICLE; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; CORONARY RISK; DRUG EFFECT; ESTROGEN THERAPY; FEMALE; ISCHEMIC HEART DISEASE; MALE; MUSCLE ISOMETRIC CONTRACTION; NONHUMAN; ORAL DRUG ADMINISTRATION; OVARIECTOMY; PRIORITY JOURNAL; RAT;

EID: 0030771869     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. ADAMS, D. J., BARAKEH, J., LASKEY, R. AND VAN BREEMEN, C.: Ion channels and regulation of intracellular calcium in vascular endothelial cells. FASEB J. 3: 2389-2400, 1989.
2. BARRET-CONNOR, E.: Heart disease in women. Fertil. Steril. 62: suppl. 2, 127S-132S, 1994.
3. BARRET-CONNOR, E. AND BUSH, T. L.: Estrogen and coronary heart disease in women. JAMA 265: 1861-1867, 1991.
4. BELL, D. R., RENSBERGER, H. J., KORINIK, D. R. AND KOSHY, A.: Estrogen pre-treatment directly potentiates endothelium-dependent vasorelaxation of porcine coronary arteries. Am. J. Physiol. 268: H377-H383, 1995.
5. BLACK, L. J., JONES, C. D. AND FALCONE, J. F.: Antagonism of estrogen action with a new benzothiophene derived antiestrogen. Life Sci. 32: 1031-1036, 1983.
6. BRYANT, H. U., MAGEE, D. E., COLE, H. W., ROWLEY, E. R., WILSON, P. K., ADRIAN, M. D., CULLINAN, G. J., YANG, N. N., GLASEBROOK, A. L. AND SATO, M.: LY117018, a selective estrogen receptor modulator (SERM) in the ovariectomized rat. J. Bone Min. Res. 10: suppl. I, S159, 1995.
7. CASTELLI, W. P.: Cardiovascular disease in women. Am. J. Obstet. Gynecol. 158: 6 (part 2), 1553-1561, 1988.
8. CHENG, D. Y., FENG, C. J., KADOWITZ, P. J. AND GHUETTER, C. A.: Effect of 17 β-estradiol on endothelium-dependent relaxation induced by acetylcholine in female rat aorta. Life Sci. 55: 187-191, 1994.
9. CONRAD, K. P., MOSHER, M. D. BRINCK-JOHNSEN, T. AND COLPOYS, M. C.: Effects of 17 β-estradiol and progesterone on prossor responses in conscious ovariectomized rats. Am. J. Physiol. 266: R1267-R1272, 1994.
10. FERRER, M., MEYER, M. AND OSOL, G.: Estrogen replacement increases β-adrenoceptor-mediated relaxation of rat mesenteric arteries. J. Vasc. Res. 33: 124-131, 1996.
11. FORSTERMANN, U., POLLOCK, J., SCHMDIT, H. H., HELLER, M. AND MURAD, F.: Calmodulin-dependent endothelium-derived relaxing factor/nitric oxide synthase activity is present in the particulate and cytosolic fractions of bovine aortic endothelial cells. Proc. Natl. Acad. Sci. USA 88: 1788-1792, 1991.
12. FURCHGOTT, R. F. AND ZAWADZKI, J. V.: The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 288: 373-376, 1980.
13. GILLIGAN, D. M., QUYYUMI, A. A., CANNON, R. O., JOHNSON, G. B. AND SCHENKE, W. H.: Effects of physiological levels of estrogen on coronary vasomotor function in postmenopausal women. Circulation 89: 2545-2551, 1994.
14. GISCLARD, V., MILLER, V. M. AND VANHOUTTE, P. M.: Effect of 17 β-estradoiol on endothelium-dependent responses in the rabbit. J. Pharmacol. Exp. Ther. 244: 19-22, 1988.
15. HARDER, D. R. AND COULSON, P. B.: Estrogen receptors and effects of estrogen on membrane electrical properties of coronary vascular smooth muscle. J. Cell. Physiol. 100: 375-382, 1979.
16. HAYASHI, T., FUKUTO, J. M., IGNARRO, L. J. AND CHAUDHURI, G.: Basal release of nitric oxide from aortic rings is greater in female rabbits than in male rabbits. Proc. Natl. Acad. Sci. USA 89: 11259-11263, 1992.
17. HISHIKAWA, K., NAKAKI, T., MARUMO, T., SUZULI, H., KATO, R. AND SARUTA, T.: Up-regulation of nitric oxide synthase by estradiol in human aortic endothelial cells. FEBS Lett. 360: 291-293, 1995.
18. IGNARRO, L. J., BYRNS, R. E., BUGA, G. M. AND WOOD, K. S.: Endothelium-derived relaxing factor from pulmonary artery and vein possesses pharmacologic and chemical properties identical to those of nitric oxide. Circ. Res. 61: 866-879, 1987.
19. IGNARRO, L. J., LIPPTON, H., EDWARDS, J. C., BARICOS, W. H., HYMAN, A. L., KADOWITZ, P. J. AND GRUETTER, C. A.: Mechanism of vascular smooth muscle relaxation by organic nitrates, nitrates, nitroprusside and nitric oxide: Evidence for the involvement of S-nitrosothiol as active intermediates. J. Pharmacol. Exp. Ther. 218: 739-749, 1981.
20. JIANG, C., SARREL, P. M., LINDSAY, D. C., POOL-WILSON, P. A. AND COLLINS, P.: Endothelium-independent relaxation of rabbit coronary artery by 17 β-estradiol. Br. J. Pharmacol. 104: 1033-1037, 1991.
21. JENSEN, J., NILAS, L. AND CHRISTIANSEN, C.: Influence of menopause on serum lipids and lipoproteins. Maturitas 12: 321-331, 1990.
22. JONES, C. D., JEVNIKAR, M. G., PIKE, A. J., PETERS, M. K., BLACK, L. J., THOPSON, A. R., FALCONE, J. F. AND CLEMENS, J. A.: Antiestrogens: Structure-activity studies in a series of 3-aroyl-2-arylbenzo[b]thiophene derivatives leading to [6-hydroxy-2-(1-hydroxyphenyl)benzo[b]thien-3-yl][4-[2-(1-piperidinyl) ethoxy] phenyl]methanone hydrochloride (LY156758), are remarkably effective estrogen antagonist with only minimal intrinsic estrogenicity. J. Med. Chem. 27: 1057-1066, 1984.
23. KAUFFMAN, R. F., BENSCH, W. R., ROUDEBUSH, R. E., COLE, H. W., BEAN, J. S., PHILLIPS, D. L., MONROE, A., CULLINAN, G. J., GLASEBROOK, A. L AND BRYANT, H. U.: Hypercholesterolemic activity of raloxifene (LY139481): Pharmacological characterization as a selective estrogen receptor modulator. J. Pharmacol. Exp. Ther. 280: 146-153, 1997.
24. KAUFFMAN, R. F. AND BRYANT, H. U.: Selective estrogen receptor modulators. Drug News Perspect. 8: 531-539, 1995.
25. LOBO, R. A.:. Cardiovascular implications of estrogen replacement therapy. Obstet. Gynecol. 75: suppl., 18S-25S (Discussion 75: suppl., 31S-35S, 1990).
26. LOBO, R. A.:. Cardiovascular implications of estrogen replacement therapy. Obstet. Gynecol. 75: suppl., 18S-25S (Discussion 75: suppl., 31S-35S, 1990).
27. MILLER, V. M. AND VANHOUTTE, P. M.: 17 β-Estradiol augments endothelium-dependent contractions to arachidonic acid in rabbit aorta. Am. J. Physiol. 258: R1502-R1507, 1990.
28. MILLER, V. M. AND VANHOUTTE, P. M.: Progesterone and modulation of endothelium-dependent responses in canine coronary arteries. Am. J. Physiol. 261: R1022-R1027, 1991.
29. PALMER, R. M., FERRIDGE, A. G. AND MONCADA, S.: Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 327: 524-526, 1987.
30. PALMER, R. M., ASHTON, D. S. AND MONCADA, S.: Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature 333: 664-666, 1988.
31. PAREDES-CARBAJAL, M. C., JUAREZ-OROPEZA, M. A., ORTIZ-MENDOZA, C. M. AND MASCHER, D.: Effects of acute and chronic estrogenic treatment on vasomotor responses of aortic rings from ovariectomized rats. Life Sci. 57: 473-486, 1995.
32. RAVI, J., MANTZOROS, C.,. S., PRABHU, A. S., RAM, J. L. AND SOWERS, J. R.: In vitro relaxation of phenylephrine and angiotensin II-contracted aortic rings by 17 β-estradiol. Am. J. Hypertens. 7: 1065-1069, 1994.
33. REES, D. D., PALMER, R. M., HODSON, H. F. AND MONCADA, S.: A specific inhibitor of nitric oxide formation from L-arginine attenuates endothelium-dependent relaxation. Br. J. Pharmacol. 96: 418-424, 1989.
34. ROSSELI, M., IMTHURUM, B., MACAS, E., KELLER, P. J. AND DUBEY, R. K.: Circulating nitrite/nitrate levels increase with follicular development: Indirect evidence for estradiol mediated NO release. Biochem. Biophys. Res. Commun. 202: 1543-1552, 1994.
35. + channels. Biochem. Biophys. Res. Commun. 214: 367-373, 1995.
36. SATO, J., GLASEBROOK, A. L. AND BRYANT, H. U.: Raloxifene: A new selective estrogen receptor modulator. J. Bone Miner. 12: suppl. 2, S9-S20, 1995.
37. STAMPFER, M. J. AND COLDITZ, G. A.: Estrogen replacement therapy and coronary heart disease: A quantitative assessment of the epidemiological evidence. Prev. Med. 20: 47-63, 1991.
38. WAKELING, A. E., VALCACCIA, B. AND NEWBOULT, E.: Non-steroidal antiestrogens: receptor binding and biological response in rat uterus, rat mammary carcinoma and human breast cancer cells. J. Steroid Biochem. 20: 111-120, 1984.
39. WALSH, B. W., SCHIFF, I., ROSNER, B., GREENBERG, L., RAVINKAR, B. AND SACKS, F. M.: Effects of postmenopausal estrogen replacement on the contraction and metabolism of plasma lipoproteins. N. Engl. J. Med. 325: 1196-1204, 1991.
40. WEINER, C. P., LIZASOAIN, L., BAYLIS, S. A., KNOWLES, R. G., CHARLES, I. G. AND MONCADA, S.: Induction of calcium-dependent nitric oxide synthase by sex hormones. Proc. Natl. Acad. Sci. USA 91: 5212-5216, 1994.
41. WEINER, C., MARTINEZ, E., ZHU, L. K., GHODSI, A. AND CHESTNUT, D.: In vitro release of endothelium-derived relaxing factor by acetylcholine is increased during the guinea pig pregnancy. Am. J. Obstet. Gynecol. 161: 1599-1605, 1989.
42. WEINER. C., ZHHU, L. K., THOMSON, L., HERRING, J. AND HESTINUT, D.: Effect of pregnancy on endothelium and smooth muscle: their role in reduced adrenergic sensitivity. Am. J. Physiol. 261: H1275-H1283, 1991.
43. WILLIAMS, S. P., SHACKELFORD, D. P., IAMS, S. G. AND MUSTAFA, S. J.: Endothelium-dependent relaxation in estrogen-treated spontaneously hypertensive rats. Eur. J. Pharmacol. 145: 205-207, 1988.
44. WILLIAMS, J. K., HONORE, E. K., WASHBURN, S. A. AND CLARKSON, T. B.: Effects of hormone replacement therapy on reactivity of atherosclerotic coronary arteries in cynomolgus monkeys. J. Am. Coll. Cardiol. 24: 1757-1761, 1994.
45. 2+ in EDRF release in rat aorta. J. Vasc. Res. 31: 18-24, 1994.